Add-on therapy with pramipexole in treatment resistant dysthymic disorder: A case report

Basit Öğe Kaydı
dc.contributor.authorZeytinci, Esra
dc.contributor.authorUguz, Faruk
dc.contributor.authorSahingoz, Mine
dc.contributor.authorSari, Serap
dc.contributor.authorKayhan, Fatih
dc.date.accessioned2020-03-26T17:37:48Z
dc.date.available2020-03-26T17:37:48Z
dc.date.issued2009
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractAdd-on therapy with pramipexole in treatment resistant dysthymic disorder: A case report Despite a wide range of alternative antidepressant drugs, a considerable rate of patients with dysthymic disorder do not response to these treatments. Usually combined pharmacological drugs and augmentation therapies are used to manage this chronic psychiatric disorder. Pramipexole, a new dopamine agonist, is approved for Parkinson's disease and restless leg syndrome but accumulating evidence suggests the usage of the drug as an antidepressant. We present a young man with a history of dysthymic disorder for 15 years who improved after adding low dose pramipexole to the prior treatment.en_US
dc.identifier.endpageS199en_US
dc.identifier.issn1017-7833en_US
dc.identifier.startpageS198en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/23253
dc.identifier.volume19en_US
dc.identifier.wosWOS:000209020900063en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherKURE ILETISIM GRUBU A Sen_US
dc.relation.ispartofKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectDysthymiaen_US
dc.subjectpramipexoleen_US
dc.subjectaugmentation therapiesen_US
dc.titleAdd-on therapy with pramipexole in treatment resistant dysthymic disorder: A case reporten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu